New 20-year data show a survival rate of 90% with few repeat surgeries after this complex operation that can only be ...
The Navitor Vision, Abbott's latest TAVI system, is designed to improve accuracy during implantation and enhance visibility ...
Navitor Vision enhances visibility and precision in TAVI procedures, offering a less invasive alternative to surgical aortic ...
Aims Exercise testing remains underused in patients with aortic stenosis (AS), partly due to concerns about an ...
Our Bureau, Mumbai Thursday, January 30, 2025, 15:15 Hrs [IST] ...
Background Cardiogenic shock (CS) induced by severe aortic stenosis (AS) is a life-threatening condition with high mortality.
Patients with low-gradient aortic stenosis and reduced LVEF, compared with patients with high-gradient aortic stenosis, have worse clinical outcomes.
Aortic stenosis, affecting nine million people globally, is often unnoticed as symptoms are mistaken for aging. This heart ...
Medpage Today on MSN14d
Aortic Stenosis Outcomes Worsen With Cardiac Amyloidosis Also in the PictureCompared with AS alone, coexisting ATTR-CA was associated with an increased risk of mortality (HR 1.3, 95% CI 1.1-1.4) in a ...
Edwards Lifesciences Corporation (NYSE:EW) shares are trading higher on Thursday. Stifel analyst Rick Wise upgraded Edwards from Hold to Buy, raising the price forecast to $90 from $75. Wise suggests ...
Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback